FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Human Disease Model Report: spinal muscular atrophy, SMN2-related therapy
Open Close
General Information
Name
spinal muscular atrophy, SMN2-related therapy
FlyBase ID
FBhh0001004
Disease Ontology Term
Parent Disease
OMIM
Overview

The SMN complex plays a role in the assembly of small nuclear ribonucleoproteins (snRNPs) into the spliceosome. In human, the two SMN complex genes SMN1 and SMN2 are nearly identical. A single nucleotide sequence difference results in different splicing patterns and production of a truncated protein from SMN2 90% of the time. Loss-of-function variants in SMN1 result in spinal muscular atrophy (see FBhh0000352); it has been shown that increased production of the full-length SMN2 protein can functionally compensate for SMN1.

A transgene carrying human Hsap\SMN2 exons 6 to 8 has been introduced into flies to test therapeutic approaches targeting SMN2 splicing (exon 7 inclusion allows production of the full-length protein). The efficacy of the compound designated PK4C9 was validated in this fly system.

[updated Apr. 2019 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: spinal muscular atrophy, SMN2-related therapy
OMIM report
Human gene(s) implicated
Symptoms and phenotype
Genetics

The SMN1 and SMN2 genes lie within the telomeric and centromeric halves, respectively, of a large, inverted duplication on chromosome 5q13. These genes share more than 99% nucleotide identity, and both are capable of encoding a 294-amino acid RNA-binding protein, SMN, that is required for efficient assembly of small nuclear ribonucleoprotein (snRNP) complexes. Homozygous loss of the SMN1 gene causes spinal muscular atrophy (SMA; 253300). Absence of SMN1 is partially compensated for by SMN2, which produces enough SMN protein to allow for relatively normal development in cell types other than motor neurons (Lefebvre et al., 1995, pubmed:7813012; Kashima et al., 2007, pubmed:17884807). [from MIM:601627; 2019.04.16]

Cellular phenotype and pathology
Molecular information

The SMN complex plays a catalyst role in the assembly of small nuclear ribonucleoproteins (snRNPs) into the spliceosome. [Gene Cards, SMN1; 2016.04.16]

SMN2 cannot fully compensate for loss of SMN1 because, although SMN2 is transcribed at a level comparable to that of SMN1, a large majority of SMN2 transcripts lack exon 7, resulting in production of a truncated, less stable SMN protein (Lefebvre et al., 1995, pubmed:7813012; Kashima et al., 2007, pubmed:17884807). [from MIM:601627; 2019.04.16]

External links
Disease synonyms
spinal muscular atrophy, SMN-related, modifier of
spinal muscular atrophy, type III, modifier of
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Many to one: 2 human to 1 Drosophila.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (0)
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (0 groups)
      Alleles Reported to Model Human Disease (Disease Ontology) (1 alleles)
      Models Based on Experimental Evidence ( 1 )
      Allele
      Disease
      Evidence
      References
      Modifiers Based on Experimental Evidence ( 0 )
      Allele
      Disease
      Interaction
      References
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      References (4)